Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8S4M

Crystal structure of Mycobacterium tuberculosis cytochrome P450 CYP125 in complex with an inhibitor

This is a non-PDB format compatible entry.
Summary for 8S4M
Entry DOI10.2210/pdb8s4m/pdb
Related7ZGL 7ZIC
DescriptorSteroid C26-monooxygenase, PROTOPORPHYRIN IX CONTAINING FE, SULFATE ION, ... (5 entities in total)
Functional Keywordscyp125, tuberculosis, cholesterol, p450, cyp, cytochrome, fragment, cholestenone, oxidoreductase
Biological sourceMycobacterium tuberculosis H37Rv
Total number of polymer chains3
Total formula weight143142.63
Authors
Snee, M.,Kavanagh, M.,Levy, C. (deposition date: 2024-02-21, release date: 2025-01-29, Last modification date: 2025-08-06)
Primary citationKavanagh, M.E.,McLean, K.J.,Gilbert, S.H.,Amadi, C.N.,Snee, M.,Tunnicliffe, R.B.,Arora, K.,Boshoff, H.I.M.,Fanourakis, A.,Rebollo-Lopez, M.J.,Ortega, F.,Levy, C.W.,Munro, A.W.,Leys, D.,Abell, C.,Coyne, A.G.
Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism.
J.Med.Chem., 68:14416-14441, 2025
Cited by
PubMed Abstract: Tuberculosis is the deadliest infectious disease in history and new drugs are urgently required to combat multidrug-resistant (MDR) strains of (). Here, we exploit the relience of on host-derived cholesterol to develop a novel class of antitubercular compounds that target CYP125 and CYP142; the enzymes that catalyze the first step of cholesterol metabolism. A combination of fragment screening and structure-based drug design was used to identify a hit compound and guide synthetic optimization of a dual CYP125/142 ligand ( 40-160 nM), which potently inhibits enzyme activity in vitro ( < 100 nM), and the growth of in extracellular (MIC 0.4-1.5 μM) and intracellular assays (IC 1.7 μM). The structural data and lead compounds reported here will help study cholesterol metabolism and guide the development of novel antibiotics to combat MDR
PubMed: 40653654
DOI: 10.1021/acs.jmedchem.5c00478
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

242500

数据于2025-10-01公开中

PDB statisticsPDBj update infoContact PDBjnumon